Sofia Shames, MD; Natalie A. Bello, MD, MPH; Allan Schwartz, MD; et al.
free access
JAMA Cardiol. 2020;5(9):991-998. doi:10.1001/jamacardio.2020.0988
This cross-sectional study assesses cardiac structure and function in elite female basketball players.
Marc A. Miller, MD; David H. Adams, MD; Dimosthenis Pandis, MD; et al.
free access
has audio
JAMA Cardiol. 2020;5(9):1000-1005. doi:10.1001/jamacardio.2020.1555
This study characterizes the burden and distribution of fluorine 18鈥搇abeled fluorodeoxyglucose uptake and late gadolinium enhancement in patients with degenerative mitral valve prolapse and ventricular ectopy.
-
Podcast:
Association Between Malignant Mitral Valve Prolapse and Sudden Cardiac Death: A Review
Guillaume Marquis-Gravel, MD, MSc; Amanda Stebbins, MA; Andrzej S. Kosinski, PhD; et al.
free access
JAMA Cardiol. 2020;5(9):1006-1010. doi:10.1001/jamacardio.2020.1725
This study describes the current geographic access to transcatheter aortic replacement centers in the United States.
Seamus P. Whelton, MD, MPH; John W. McEvoy, MB, BCh, MHS; Leslee Shaw, PhD; et al.
free access
has audio
JAMA Cardiol. 2020;5(9):1011-1018. doi:10.1001/jamacardio.2020.1731
This cohort study examines the association of systolic blood pressure levels with the risk of atherosclerotic cardiovascular disease in persons without atherosclerotic cardiovascular disease risk factors.
-
Podcast:
Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease Without Risk Factors
-
Invited Commentary
What Is a Normal Blood Pressure?
Daniel W. Jones, MD
JAMA Cardiol
-
Podcast:
Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease Without Risk Factors
Neil Mehta, MBBS; Ankur Kalra, MD; Amy S. Nowacki, PhD; et al.
free access
JAMA Cardiol. 2020;5(9):1020-1026. doi:10.1001/jamacardio.2020.1855
This cohort study assesses the association between use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with the likelihood of testing positive for coronavirus disease 2019 (COVID-19).
Alison Brann, MD; Satit Janvanishstaporn, MD; Barry Greenberg, MD
free access
JAMA Cardiol. 2020;5(9):1027-1035. doi:10.1001/jamacardio.2020.2081
This cohort study evaluates whether risk of clinical events experienced by patients with heart failure with midrange ejection fraction varies according to whether left ventricular ejection fraction improved or deteriorated into the range of 40% to 50% from previous measurements.